Additionally, genetic loss of PRMT7 induced reprogramming of glycine metabolism that eradicated leukemic stem cells in mouse and human models of chronic myeloid leukemia (CML) [87]. The gene discussed is PRMT7; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.